Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Mehta is a 2018 Seattle Met Top Doctor Award winner. He enjoys working with patients and family members. There are a wide variety of treatment options available for nearly every patient, so it is important to spend as much time as is needed in order to weight the benefits and risks to any particular approach. He feels that it is important that communication is open and honest. The goals of treatment, whether it is going for cure or maximizing quality of life should be openly discussed and re-discussed as the need arises.  For more about Dr.

Refining Radiation Therapy for Lung Cancer, A Historical Perspective
GRACEcast-121_Rad_Refining Radiation Therapy for LC, Pt 1: A Historical Perspective, by Dr. Mehta
Author
Vivek Mehta, MD., GRACE Faculty
Image

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, provides a historical perspective of radiation therapy as it transitions to a more targeted treatment approach.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
Las biopsias líquidas están revolucionando la forma en que combatimos el cáncer, ofreciendo un futuro donde la detección y el tratamiento son más rápidos, precisos y menos invasivos.
Image
Videoteca de Cáncer de Pulmon - 2025
Video
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente en cáncer de pulmón. El Dr. Raez aborda la terapia para cánceres de pulmón EGFR y ALK, además de analizar otros tres temas de actualidad. La Dra. Viola y la Dra. Riaño también contribuyen a esta videoteca, cada una presentando tres temas relevantes sobre el cáncer de pulmón.
Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.

Recent Comments

JOIN THE CONVERSATION
HOW I GOT CURED OF MY PARKINSON DISEASE
By NellyArmstrong on
HOW I GOT CURED POOF MY DISEASE
By NellyArmstrong on
Hi there, thank you for…
By kidjaialai on
Thanks for sharing—amazing…
By MakaylaLove on